Skip to Content

Aminolevulinic acid topical Pregnancy and Breastfeeding Warnings

Aminolevulinic acid topical is also known as: Ameluz, Levulan Kerastick

Aminolevulinic acid topical Pregnancy Warnings

Animal studies have not shown reproductive toxicity. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be given to a pregnant woman only if clearly needed.

US FDA pregnancy category: C

See references

Aminolevulinic acid topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comments:The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Levulan Kerastick (aminolevulinic acid)" Berlex, Richmond, CA.

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Levulan Kerastick (aminolevulinic acid)" Berlex, Richmond, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide